FibroGen Inc.
FGEN | NASDAQ
$9.07
-$0.15 (-1.63%)
At close: Jan 12, 2026, 09:30 AM ET
Market Data
Market Cap $36.69M
Enterprise Value $-54.63M
Beta 0.77
Average Volume N/A
Shares Outstanding (Diluted) 4.05M
Shares Change YoY 0.15%
Institutional Ownership N/A
Exchange N/A
ISIN N/A
Price Performance
Price Change 1M N/A
Price Change 3M N/A
Price Change 6M N/A
Price Change YTD N/A
Price Change 1Y N/A
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) 10.7%
1Y CAGR (ann.) -43.0%
5Y CAGR (ann.) -60.0%
All-Time CAGR -30.5%
Valuation
PE Ratio 0.20
Forward PE N/A
PEG Ratio 0.00
Forward PEG 0.01
PS Ratio 7.95
Forward PS 6.00
PB Ratio -4.51
P/FCF Ratio -0.96
P/Adj. FCF Ratio -0.87
P/OCF Ratio -0.96
EV/Sales -11.83
EV/EBIT 4.94
EV/EBITDA 1.45
EV/FCF 1.44
Earnings Yield 499.4%
FCF Yield -103.7%
Adj. FCF Yield -114.6%
Financial Health
Net Cash $91.32M
Total Debt $0
Cash & Short-Term Investments $91.32M
Total Assets $101.08M
Current Ratio 2.69
Quick Ratio 2.59
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage 82.62
Altman Z-Score -23.07
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 78.4%
Operating Profit Margin -1090.0%
EBITDA Margin -817.5%
Net Profit Margin 3968.6%
FCF Margin -824.6%
Adj. FCF Margin -910.9%
SBC / Revenue 86.3%
SBC Impact (per share) -10.5%
Returns
Return on Assets 181.2%
Return on Equity -2443.6%
Return on Invested Capital -77.4%
Return on Capital Employed -77.4%
Return on Tangible Assets 181.2%
Historical Growth (CAGR)
Revenue CAGR 3Y -67.2%
Revenue CAGR 5Y -51.5%
Revenue CAGR 10Y -29.9%
EPS CAGR 3Y 198.8%
EPS CAGR 5Y 149.4%
EPS CAGR 10Y 102.2%
FCF CAGR 3Y 93.5%
FCF CAGR 5Y 32.4%
FCF CAGR 10Y -7.2%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 14
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Nov 9, 2025
EPS Estimate (next Q) -$4.01
EPS Growth Est (next Q) -5.7%
Revenue Est (next Q) $2.43M
Revenue Growth Est (next Q) -94.8%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value $1,132.50
Lynch Upside 12386.2%
Price Target $28
Price Target Upside 208.7%
Cash Flow
Operating Cash Flow $-38.05M
Free Cash Flow $-38.06M
Adj. Free Cash Flow $-42.05M
FCF Per Share -$9.40
OCF Per Share -$9.40
OCF/S Ratio -824.4%
Income Statement
Revenue $4.62M
Gross Profit $3.62M
Operating Income $-50.32M
EBITDA $-37.74M
Net Income $183.19M
EPS (Diluted) $45.30
Revenue / Employee N/A
Profit / Employee N/A
Employees N/A
Add to Watchlist
Select watchlists to add or remove FGEN